Toshiyuki Nagi

Recent publications · Crossref

5 total works indexed

1. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

   · 2018 · cited 4,660x

2. Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

   · 2010 · cited 4,549x

3. Guidelines for the use and interpretation of assays for monitoring autophagy

   · 2012 · cited 2,919x

4. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

   · 2019 · cited 2,788x

5. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β

   · 2000 · cited 2,750x

via Crossref · CC0